Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Life Sciences|January 1, 1990
Iodobenzamide for in vivo exploration of central dopamine receptors: evaluation in animal models of supersensitivityS Chalon, C Guimbal, D Guilloteau, et al.
European Journal of Nuclear Medicine|January 1, 1988
Comparison of MIBG and monoamines uptake mechanisms: pharmacological animal and blood platelets studiesD Guilloteau, S Chalon, J L Baulieu, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: synthesis and preliminary in vivo studyS Chalon, Y Frangin, D Guilloteau, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporterP Emond, L Garreau, S Chalon, et al.
Vascular Medicine (London, England)|June 4, 1999
L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover studyO Tangphao, S Chalon, A M Coulston, et al.
Synapse (New York, N.Y.)|September 1, 1996
Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors: a comparative studyC Pellevoisin, D Guilloteau, J L Baulieu, et al.
Nuclear Medicine and Biology|February 1, 1995
Synthesis of 4'-iodo-5-methoxy-valerophenone O-(2-aminoethyl)oxime as an agent for exploration of serotoninergic transporterC Branger, L Garreau, A M Dognon, et al.
Nuclear Medicine and Biology|August 1, 1995
Iododerivative of pargyline: a potential tracer for the exploration of monoamine oxidase sites by SPECTI Lena, J E Ombetta, S Chalon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 23, 2001
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's diseaseE Bezard, S Dovero, C Prunier, et al.
Nuclear Medicine and Biology|July 1, 1995
Synthesis and characterization of [125I]N-(2-aminoethyl)-4-iodobenzamide as a selective monoamine oxidase B inhibitorH Rafii, S Chalon, J E Ombetta, et al.
Pageof 9